# AMPHADASE

NDC: 0548-9090
Generic name: hyaluronidase
Labeler / Manufacturer: Amphastar Pharmaceuticals, Inc.
Product type: HUMAN PRESCRIPTION DRUG
Marketing category: Biologic License Application
Dosage form: INJECTION
Routes: SUBCUTANEOUS
Marketing started: 20041026

FDA application: BLA021665

## Active ingredients

- HYALURONIDASE: 150 [USP'U]/mL

## Pharmacological class

—

## External sources

- openFDA: https://api.fda.gov/drug/ndc.json?search=product_ndc:"0548-9090"
- FDA NDC Directory: https://www.accessdata.fda.gov/scripts/cder/ndc/dsp_searchresult.cfm?p_ndc=0548-9090
- DailyMed: https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=8396ea96-7cb5-4e26-87a4-90bca9c3c6dd